BioCentury
ARTICLE | Financial News

Voyager raises $54M in follow-on

November 8, 2017 9:47 PM UTC

Voyager Therapeutics Inc. (NASDAQ:VYGR) raised $54 million late Tuesday through the sale of 4.5 million shares at $12 in a follow-on underwritten by Morgan Stanley, Cowen, Stifel, Wells Fargo Securities and Nomura. The price is a 27% discount to Voyager's close of $16.54 on Monday, when it proposed after hours to raise $75 million.

In September, the company reported that VY-AADC01 led to durable, dose-dependent improvements across multiple measures of motor function in a Phase Ib trial in Parkinson's disease patients (see BioCentury Extra, Sept 6)...